14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $3.05 $4.30 Wednesday, 1st May 2024 GERN stock ended at $4.08. This is 3.82% more than the trading day before Tuesday, 30th Apr 2024. During the day the stock fluctuated 8.51% from a day low at $3.88 to a day high of $4.21.
90 days $1.64 $4.30
52 weeks $1.64 $4.30

Historical Geron Corporation prices

Date Open High Low Close Volume
Mar 28, 2023 $2.31 $2.36 $2.16 $2.17 4 127 407
Mar 27, 2023 $2.33 $2.38 $2.30 $2.34 3 835 982
Mar 24, 2023 $2.30 $2.35 $2.24 $2.33 3 716 835
Mar 23, 2023 $2.31 $2.35 $2.20 $2.28 4 538 383
Mar 22, 2023 $2.34 $2.42 $2.25 $2.30 6 202 968
Mar 21, 2023 $2.46 $2.48 $2.32 $2.34 6 741 772
Mar 20, 2023 $2.53 $2.53 $2.40 $2.46 3 753 606
Mar 17, 2023 $2.62 $2.65 $2.36 $2.53 26 314 573
Mar 16, 2023 $2.62 $2.71 $2.58 $2.65 3 970 550
Mar 15, 2023 $2.68 $2.75 $2.59 $2.62 6 192 687
Mar 14, 2023 $2.70 $2.81 $2.69 $2.74 5 097 045
Mar 13, 2023 $2.50 $2.69 $2.50 $2.68 5 751 670
Mar 10, 2023 $2.69 $2.69 $2.43 $2.57 11 052 491
Mar 09, 2023 $2.81 $2.87 $2.64 $2.68 5 400 594
Mar 08, 2023 $2.84 $2.87 $2.79 $2.82 2 775 525
Mar 07, 2023 $2.82 $2.84 $2.76 $2.79 2 909 691
Mar 06, 2023 $2.89 $2.91 $2.79 $2.83 3 531 665
Mar 03, 2023 $2.81 $2.93 $2.78 $2.88 3 175 749
Mar 02, 2023 $2.77 $2.84 $2.73 $2.80 2 515 635
Mar 01, 2023 $2.77 $2.83 $2.77 $2.78 3 009 672
Feb 28, 2023 $2.71 $2.81 $2.71 $2.78 7 778 563
Feb 27, 2023 $2.71 $2.79 $2.71 $2.74 2 332 982
Feb 24, 2023 $2.72 $2.80 $2.69 $2.70 2 838 032
Feb 23, 2023 $2.86 $2.87 $2.71 $2.78 3 572 443
Feb 22, 2023 $2.82 $2.89 $2.75 $2.83 3 981 712
Click to get the best stock tips daily for free!

About Geron Corporation

Geron Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hematologic myeloid malignancies for the treatment of low or intermediate-1 risk myelodysplastic syndromes a... GERN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT